<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to evaluate the usefulness of urinary <z:chebi fb="0" ids="28101">N(1),N(12)-diacetylspermine</z:chebi> (DiAcSpm) measured by the <z:chebi fb="0" ids="30050">colloidal gold</z:chebi> aggregation method as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The preoperative urine of 113 CRC patients was collected, and the urinary DiAcSpm was measured by a reagent kit for DiAcSpm determination based on <z:chebi fb="0" ids="30050">colloidal gold</z:chebi> aggregation using automatic biochemical analyzers </plain></SENT>
<SENT sid="2" pm="."><plain>The urinary DiAcSpm levels significantly correlated with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-Node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e> (TNM) stage </plain></SENT>
<SENT sid="3" pm="."><plain>The positive rates of urinary DiAcSpm were significantly higher than those of serum carcinoembryonic antigen (CEA) or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> antigen 19-9 (CA19-9) in stages 0+I, II, III and IV </plain></SENT>
<SENT sid="4" pm="."><plain>The positive rates of urinary DiAcSpm were also significantly higher than those of serum CEA or CA19-9 in the early and advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> groups according to the Japan Classification of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, urinary DiAcSpm, measured by a reagent kit for DiAcSpm determination based on <z:chebi fb="0" ids="30050">colloidal gold</z:chebi> aggregation, may be useful as a non-invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>